275 related articles for article (PubMed ID: 32380038)
1. FBXW7 promotes pathological cardiac hypertrophy by targeting EZH2-SIX1 signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Exp Cell Res; 2020 Aug; 393(1):112059. PubMed ID: 32380038
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q
Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2.
Yang T; Zhang GF; Chen XF; Gu HH; Fu SZ; Xu HF; Feng Q; Ni YM
Biochem Biophys Res Commun; 2013 Jul; 436(4):578-84. PubMed ID: 23727574
[TBL] [Abstract][Full Text] [Related]
4. MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
Wang L; Qin D; Shi H; Zhang Y; Li H; Han Q
Biomed Res Int; 2019; 2019():1580982. PubMed ID: 31341888
[TBL] [Abstract][Full Text] [Related]
5. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-223 Tips the Balance of Pro- and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy.
Yang L; Li Y; Wang X; Mu X; Qin D; Huang W; Alshahrani S; Nieman M; Peng J; Essandoh K; Peng T; Wang Y; Lorenz J; Soleimani M; Zhao ZQ; Fan GC
J Biol Chem; 2016 Jul; 291(30):15700-13. PubMed ID: 27226563
[TBL] [Abstract][Full Text] [Related]
7. The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage.
Hänle-Kreidler S; Richter KT; Hoffmann I
J Biol Chem; 2022 Dec; 298(12):102703. PubMed ID: 36395886
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
9. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
Mei ZL; Wang HB; Hu YH; Xiong L
Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
[TBL] [Abstract][Full Text] [Related]
10. JMJD1A Represses the Development of Cardiomyocyte Hypertrophy by Regulating the Expression of
Zang R; Tan Q; Zeng F; Wang D; Yu S; Wang Q
Biomed Res Int; 2020; 2020():5081323. PubMed ID: 32461996
[TBL] [Abstract][Full Text] [Related]
11. MiR322 mediates cardioprotection against ischemia/reperfusion injury via FBXW7/notch pathway.
Chen Z; Su X; Shen Y; Jin Y; Luo T; Kim IM; Weintraub NL; Tang Y
J Mol Cell Cardiol; 2019 Aug; 133():67-74. PubMed ID: 31150734
[TBL] [Abstract][Full Text] [Related]
12. Fbxw7 increases CCL2/7 in CX3CR1hi macrophages to promote intestinal inflammation.
He J; Song Y; Li G; Xiao P; Liu Y; Xue Y; Cao Q; Tu X; Pan T; Jiang Z; Cao X; Lai L; Wang Q
J Clin Invest; 2019 Jun; 129(9):3877-3893. PubMed ID: 31246581
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis.
Delgado-Olguín P; Huang Y; Li X; Christodoulou D; Seidman CE; Seidman JG; Tarakhovsky A; Bruneau BG
Nat Genet; 2012 Jan; 44(3):343-7. PubMed ID: 22267199
[TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine.
Zhao Z; Lv J; Guo N; Guo Q; Zeng S; Fang Y; Chen W; Wang Z
Curr Drug Targets; 2023; 24(4):371-378. PubMed ID: 36734909
[TBL] [Abstract][Full Text] [Related]
17. Transcribed Ultraconserved Regions, Uc.323, Ameliorates Cardiac Hypertrophy by Regulating the Transcription of CPT1b (Carnitine Palmitoyl transferase 1b).
Sun Y; Fan W; Xue R; Dong B; Liang Z; Chen C; Li J; Wang Y; Zhao J; Huang H; Jiang J; Wu Z; Dai G; Fang R; Yan Y; Yang T; Huang ZP; Dong Y; Liu C
Hypertension; 2020 Jan; 75(1):79-90. PubMed ID: 31735087
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22.
Yang X; Tao L; Zhu J; Zhang S
Med Sci Monit; 2019 Dec; 25():9609-9617. PubMed ID: 31840653
[TBL] [Abstract][Full Text] [Related]
19. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
Wang NN; Wang J; Tan HL; Wang YG; Gao Y; Ma ZC
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1642-1647. PubMed ID: 31090329
[TBL] [Abstract][Full Text] [Related]
20. Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1.
Yu YH; Hu ZY; Li MH; Li B; Wang ZM; Chen SL
Int J Clin Exp Pathol; 2015; 8(3):2582-9. PubMed ID: 26045764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
